Cargando…

Treatment Resistant Atopic Dermatitis: Challenges and Solutions [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928468/ https://www.ncbi.nlm.nih.gov/pubmed/31908516 http://dx.doi.org/10.2147/CCID.S241314

Ejemplares similares

Treatment-resistant atopic dermatitis: challenges and solutions
por: Johnson, Brian B, et al.
Publicado: (2019)

Corrigendum to “Evaluation of Candida Colonization and Specific Humoral Responses against Candida albicans in Patients with Atopic Dermatitis”
por: Ghaffari, Javad, et al.
Publicado: (2015)

Corrigendum: Association of DOCK8, IL17RA, and KLK12 Polymorphisms with Atopic Dermatitis in Koreans
por: Heo, Won Il, et al.
Publicado: (2020)

Corrigendum to “Influence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4(+) CD4(+) Lymphocytes in Dogs with Atopic Dermatitis: Open Study”
por: Fujimura, Masato, et al.
Publicado: (2016)

Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions [Corrigendum]
Publicado: (2021)

Improving intraoperative handoffs for ambulatory anesthesia: challenges and solutions for the anesthesiologist [Corrigendum]
Publicado: (2019)

Corrigendum to: Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions
por: Cushing, Kelly C, et al.
Publicado: (2021)

Corrigendum to “Hepatic Iron Quantification on 3 Tesla (3 T) Magnetic Resonance (MR): Technical Challenges and Solutions”
por: Anwar, Muhammad, et al.
Publicado: (2018)

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]
Publicado: (2021)

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
por: Cherin, Patrick, et al.
Publicado: (2015)

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Publicado: (2016)

Corrigendum to “Overcoming scarring in the urethra: Challenges for tissue engineering”
por: Simsek, Abdulmuttalip, et al.
Publicado: (2019)

Corrigendum to “CXCL12/CXCR4 signaling induced itch and pain sensation in a murine model of allergic contact dermatitis”
Publicado: (2020)

Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges [Corrigendum]
Publicado: (2016)

Corrigendum to “Myocardial Infarction in Neonates: A Diagnostic and Therapeutic Challenge”
por: Rodríguez Martínez, Manuel, et al.
Publicado: (2023)

Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum]
Publicado: (2021)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Publicado: (2019)

Big data in pharmacy practice: current use, challenges, and the future [Corrigendum]
Publicado: (2019)

Challenges to detect glaucomatous visual field loss with pupil perimetry [Corrigendum]
Publicado: (2019)

Challenges and Future Trends in Atopic Dermatitis
por: Gatmaitan, Julius Garcia, et al.
Publicado: (2023)

Corrigendum to “Impact and Challenges of Mesenchymal Stem Cells in Medicine: An Overview of the Current Knowledge”
por: Menaa, Farid, et al.
Publicado: (2019)

Corrigendum to: Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Publicado: (2023)

Efficacy of Chloral Hydrate Oral Solution for Sedation in Pediatrics: a Systematic Review and Meta-Analysis [Corrigendum]
Publicado: (2022)

Treatments for atopic dermatitis
por: Ross, Gayle
Publicado: (2023)

On Carlsbad Treatment for Anglo-Indians: Corrigendum
Publicado: (1891)

Corrigendum to “Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease”
por: Feldt-Rasmussen, Ulla, et al.
Publicado: (2017)

Corrigendum: Relative Measures of Association for Binary Outcomes: Challenges and Recommendations for the Global Health Researcher
por: Gallis, John A., et al.
Publicado: (2020)

Corrigendum: Biologically engineered microbes for bioremediation of electronic waste: Wayposts, challenges and future directions
Publicado: (2022)

Corrigendum to “Solution of Radiative Transfer Equation with a Continuous and Stochastic Varying Refractive Index by Legendre Transform Method”
por: Baazaoui, R., et al.
Publicado: (2016)

Smartphone Health Assessment for Relapse Prevention (SHARP): a digital solution toward global mental health – CORRIGENDUM
por: Rodriguez-Villa, Elena, et al.
Publicado: (2021)

Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
Publicado: (2017)

Corrigendum to: Limited evolutionary conservation of multidrug resistance and collateral sensitivity
por: Apjok, Gábor, et al.
Publicado: (2021)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis [Corrigendum]
Publicado: (2022)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
Publicado: (2013)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events [Corrigendum]
Publicado: (2013)

Corrigendum to “On a Nonlinear Wave Equation Associated with Dirichlet Conditions: Solvability and Asymptotic Expansion of Solutions in Many Small Parameters”
por: Ngoc, Le Thi Phuong, et al.
Publicado: (2017)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]
Publicado: (2018)

Corrigendum to “Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist”
por: Krishnan, Sowmya, et al.
Publicado: (2017)

NICE shared decision making guidelines and mental health: challenges for research, practice and implementation – CORRIGENDUM
por: Zisman-Ilani, Yaara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ouvfom555b0bt7ukoae278690g